UNC Metastatic Cancer Radiation Therapy Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06306924

Enrollment

2000

Registered

2024-03-12

Start date

2024-04-21

Completion date

2033-05-01

Last updated

2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Metastatic Cancer

Keywords

radiation therapy

Brief summary

The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.

Interventions

RADIATIONRadiation therapy

Subjects with metastatic cancer receive radiation therapy.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

Written informed consent was obtained to participate in the study and HIPAA Authorization for release of personal health information. Ability to understand and willingness to sign informed consent Diagnosed with or is suspected to have metastatic cancer. Age ≥ 18 years at the time of consent. Evaluated to receive radiation therapy as part of their standard-of-care treatment plan.

Exclusion criteria

All participants must not meet any of the following

Design outcomes

Primary

Measure	Time frame	Description
Clinical Data	Up to 1 month	Clinical data and radiological assessments from participants with metastatic cancer receiving radiation therapy as a part of the standard of care will be collected.

Secondary

Measure	Time frame	Description
Patient reported outcomes (PRO)	Baseline, 1 month, 3 months, 6 months, 9 months, and 12 months	Patient reported outcomes (PRO) from participants will be collected at different time points.

Countries

United States

Contacts

CONTACTKadiata Toumbou

kadiata@email.unc.edu(202) 569-3721

CONTACTVictoria Xu

victoria_xu@med.unc.edu

PRINCIPAL_INVESTIGATORShivani Sud, MD

UNC Lineberger Comprehensive Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026